Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals

Zahid A Butt,1 Nabin Shrestha,1 Dionne Gesink,2 Michelle Murti,2,3 Jane A Buxton,1,4 Mark Gilbert,4 Robert F Balshaw,4 Stanley Wong,4 Margot Kuo,4 Jason Wong,1,4 Amanda Yu,4 Maria Alvarez,4 Hasina Samji,4 David Roth,4 Theodora Consolacion,4 Mark W Hull,5,6 Gina Ogilvie,1,4 Mark W Tyndall,1,4 Mel Kra...

Full description

Bibliographic Details
Main Authors: Butt ZA, Shrestha N, Gesink D, Murti M, Buxton JA, Gilbert M, Balshaw RF, Wong S, Kuo M, Wong J, Yu A, Alvarez M, Samji H, Roth D, Consolacion T, Hull MW, Ogilvie G, Tyndall MW, Krajden M, Janjua NZ
Format: Article
Language:English
Published: Dove Medical Press 2018-08-01
Series:Clinical Epidemiology
Subjects:
HIV
Online Access:https://www.dovepress.com/effect-of-opioid-substitution-therapy-and-mental-health-counseling-on--peer-reviewed-article-CLEP
id doaj-65292c3f04a141a48a1d94f7f56ec252
record_format Article
spelling doaj-65292c3f04a141a48a1d94f7f56ec2522020-11-24T22:09:16ZengDove Medical PressClinical Epidemiology1179-13492018-08-01Volume 101127114540228Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individualsButt ZAShrestha NGesink DMurti MBuxton JAGilbert MBalshaw RFWong SKuo MWong JYu AAlvarez MSamji HRoth DConsolacion THull MWOgilvie GTyndall MWKrajden MJanjua NZZahid A Butt,1 Nabin Shrestha,1 Dionne Gesink,2 Michelle Murti,2,3 Jane A Buxton,1,4 Mark Gilbert,4 Robert F Balshaw,4 Stanley Wong,4 Margot Kuo,4 Jason Wong,1,4 Amanda Yu,4 Maria Alvarez,4 Hasina Samji,4 David Roth,4 Theodora Consolacion,4 Mark W Hull,5,6 Gina Ogilvie,1,4 Mark W Tyndall,1,4 Mel Krajden,1,4,7 Naveed Z Janjua1,4 1School of Population and Public Health, University of British Columbia, Vancouver, BC, 2Dalla Lana School of Public Health, University of Toronto, 3Public Health Ontario, Toronto, ON, 4Clinical Prevention Services, British Columbia Centre for Disease Control, 5Division of AIDS, Faculty of Medicine, University of British Columbia, 6AIDS Research Program, British Columbia Centre for Excellence in HIV/AIDS, 7BCCDC Public Health Laboratory, Vancouver, BC, Canada Background: Understanding differences in HIV incidence among people living with hepatitis C virus (HCV) can help inform strategies to prevent HIV infection. We estimated the time to HIV diagnosis among HCV-positive individuals and evaluated factors that could affect HIV-infection risk in this population.Patients and methods: The British Columbia Hepatitis Testers Cohort includes all BC residents (~1.5 million: about a third of all residents) tested for HCV and HIV from 1990 to 2013 and is linked to administrative health care and mortality data. All HCV-positive and HIV-negative individuals were followed to measure time to HIV acquisition (positive test) and identify factors associated with HIV acquisition. Adjusted HRs (aHRs) were estimated using Cox proportional-hazard regression.Results: Of 36,077 HCV-positive individuals, 2,169 (6%) acquired HIV over 266,883 years of follow-up (overall incidence of 8.1 per 1,000 person years). Overall median (IQR) time to HIV infection was 3.87 (6.06) years. In Cox regression, injection-drug use (aHR 1.47, 95% CI 1.33–1.63), HBV infection (aHR 1.34, 95% CI 1.16–1.55), and being a man who has sex with men (aHR 2.78, 95% CI 2.14–3.61) were associated with higher risk of HIV infection. Opioid-substitution therapy (OST) (aHR 0.59, 95% CI 0.52–0.67) and mental health counseling (aHR 0.48, 95% CI 0.43–0.53) were associated with lower risk of HIV infection.Conclusion: Injection-drug use, HBV coinfection, and being a man who has sex with men were associated with increased HIV risk and engagement in OST and mental health counseling were associated with reduced HIV risk among HCV-positive individuals. Improving access to OST and mental health services could prevent transmission of HIV and other blood-borne infections, especially in settings where access is limited. Keywords: opioid-substitution therapy, mental health counseling, HIV, risk, hepatitishttps://www.dovepress.com/effect-of-opioid-substitution-therapy-and-mental-health-counseling-on--peer-reviewed-article-CLEPOpioid Substitution Therapymental health counsellingHIVRiskHepatitis
collection DOAJ
language English
format Article
sources DOAJ
author Butt ZA
Shrestha N
Gesink D
Murti M
Buxton JA
Gilbert M
Balshaw RF
Wong S
Kuo M
Wong J
Yu A
Alvarez M
Samji H
Roth D
Consolacion T
Hull MW
Ogilvie G
Tyndall MW
Krajden M
Janjua NZ
spellingShingle Butt ZA
Shrestha N
Gesink D
Murti M
Buxton JA
Gilbert M
Balshaw RF
Wong S
Kuo M
Wong J
Yu A
Alvarez M
Samji H
Roth D
Consolacion T
Hull MW
Ogilvie G
Tyndall MW
Krajden M
Janjua NZ
Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals
Clinical Epidemiology
Opioid Substitution Therapy
mental health counselling
HIV
Risk
Hepatitis
author_facet Butt ZA
Shrestha N
Gesink D
Murti M
Buxton JA
Gilbert M
Balshaw RF
Wong S
Kuo M
Wong J
Yu A
Alvarez M
Samji H
Roth D
Consolacion T
Hull MW
Ogilvie G
Tyndall MW
Krajden M
Janjua NZ
author_sort Butt ZA
title Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals
title_short Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals
title_full Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals
title_fullStr Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals
title_full_unstemmed Effect of opioid-substitution therapy and mental health counseling on HIV risk among hepatitis C-infected individuals
title_sort effect of opioid-substitution therapy and mental health counseling on hiv risk among hepatitis c-infected individuals
publisher Dove Medical Press
series Clinical Epidemiology
issn 1179-1349
publishDate 2018-08-01
description Zahid A Butt,1 Nabin Shrestha,1 Dionne Gesink,2 Michelle Murti,2,3 Jane A Buxton,1,4 Mark Gilbert,4 Robert F Balshaw,4 Stanley Wong,4 Margot Kuo,4 Jason Wong,1,4 Amanda Yu,4 Maria Alvarez,4 Hasina Samji,4 David Roth,4 Theodora Consolacion,4 Mark W Hull,5,6 Gina Ogilvie,1,4 Mark W Tyndall,1,4 Mel Krajden,1,4,7 Naveed Z Janjua1,4 1School of Population and Public Health, University of British Columbia, Vancouver, BC, 2Dalla Lana School of Public Health, University of Toronto, 3Public Health Ontario, Toronto, ON, 4Clinical Prevention Services, British Columbia Centre for Disease Control, 5Division of AIDS, Faculty of Medicine, University of British Columbia, 6AIDS Research Program, British Columbia Centre for Excellence in HIV/AIDS, 7BCCDC Public Health Laboratory, Vancouver, BC, Canada Background: Understanding differences in HIV incidence among people living with hepatitis C virus (HCV) can help inform strategies to prevent HIV infection. We estimated the time to HIV diagnosis among HCV-positive individuals and evaluated factors that could affect HIV-infection risk in this population.Patients and methods: The British Columbia Hepatitis Testers Cohort includes all BC residents (~1.5 million: about a third of all residents) tested for HCV and HIV from 1990 to 2013 and is linked to administrative health care and mortality data. All HCV-positive and HIV-negative individuals were followed to measure time to HIV acquisition (positive test) and identify factors associated with HIV acquisition. Adjusted HRs (aHRs) were estimated using Cox proportional-hazard regression.Results: Of 36,077 HCV-positive individuals, 2,169 (6%) acquired HIV over 266,883 years of follow-up (overall incidence of 8.1 per 1,000 person years). Overall median (IQR) time to HIV infection was 3.87 (6.06) years. In Cox regression, injection-drug use (aHR 1.47, 95% CI 1.33–1.63), HBV infection (aHR 1.34, 95% CI 1.16–1.55), and being a man who has sex with men (aHR 2.78, 95% CI 2.14–3.61) were associated with higher risk of HIV infection. Opioid-substitution therapy (OST) (aHR 0.59, 95% CI 0.52–0.67) and mental health counseling (aHR 0.48, 95% CI 0.43–0.53) were associated with lower risk of HIV infection.Conclusion: Injection-drug use, HBV coinfection, and being a man who has sex with men were associated with increased HIV risk and engagement in OST and mental health counseling were associated with reduced HIV risk among HCV-positive individuals. Improving access to OST and mental health services could prevent transmission of HIV and other blood-borne infections, especially in settings where access is limited. Keywords: opioid-substitution therapy, mental health counseling, HIV, risk, hepatitis
topic Opioid Substitution Therapy
mental health counselling
HIV
Risk
Hepatitis
url https://www.dovepress.com/effect-of-opioid-substitution-therapy-and-mental-health-counseling-on--peer-reviewed-article-CLEP
work_keys_str_mv AT buttza effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT shresthan effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT gesinkd effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT murtim effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT buxtonja effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT gilbertm effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT balshawrf effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT wongs effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT kuom effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT wongj effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT yua effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT alvarezm effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT samjih effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT rothd effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT consolaciont effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT hullmw effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT ogilvieg effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT tyndallmw effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT krajdenm effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
AT janjuanz effectofopioidsubstitutiontherapyandmentalhealthcounselingonhivriskamonghepatitiscinfectedindividuals
_version_ 1725812724931231744